Basics Merck & Co., Inc. Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $204.7B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 0.89% Avg Daily Range (30 D): $0.90 | 1.11% Avg Daily Range (90 D): $1.19 | 1.46% Institutional Daily Volume Avg Daily Volume: 10.6M Avg Daily Volume (30 D): 10.73M Avg Daily Volume (90 D): 11.8M Trade Size Avg Trade Size (Sh.): 177 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 167,415 Avg Inst. Trade: $5.5M Avg Inst. Trade (30 D): $14.81M Avg Inst. Trade (90 D): $13.23M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 30 Market Closing Trades Avg Closing Trade: $87.29M Avg Closing Trade (30 D): $231.53M Avg Closing Trade (90 D): $242.62M Avg Closing Volume: 1.18M     News Jul 24, 2025 @ 5:00 PM Non-Hodgkin’s Lymphoma Market Forecast to S... Source: Delveinsight Jul 20, 2025 @ 1:25 PM Should You Forget Pfizer and Buy This Magnificent ... Source: Reuben Gregg Brewer Jul 19, 2025 @ 8:11 PM Could an Investment in SCHD Help Supplement Social... Source: James Brumley Jul 19, 2025 @ 6:54 PM MERCK ALERT: Bragar Eagel & Squire, P.C. is Invest... Source: Bragar Eagel & Squire, P.C. Jul 18, 2025 @ 3:30 PM European Commission Grants Conditional Approval of... Source: Springworks Therapeutics Financials   TTM Q1 2025 Q4 2024 Basic EPS $6.89 $2.01 $1.48 Diluted EPS $6.87 $2.01 $1.48 Revenue $ 63.92B $ 15.53B $ 15.62B Gross Profit $ 48.85B $ 12.11B $ 11.8B Net Income / Loss $ 17.45B $ 5.09B $ 3.74B Operating Income / Loss $ 20.17B $ 5.9B $ 4.17B Cost of Revenue $ 15.07B $ 3.42B $ 3.83B Net Cash Flow $ 3.06B $ -4586M $ -1370M PE Ratio 12.23